D-0612-2017 Class II Terminated

Recalled by Fougera Pharmaceuticals Inc. — Melville, NY

FDA drug recall D-0612-2017 was initiated by Fougera Pharmaceuticals Inc. on Mar 2, 2017 and is designated Class II. Reason for recall: Labeling: Label Mixup; Unit boxes labeled as Desonide Ointment 0.05% may contain tubes of Desonide Ointment labeled as Ketoconazole Cream The recall status is terminated (terminated Jul 2, 2018). Affected quantity: 14,665 tubes.

Recall details

Product Type
Drugs
Report Date
Mar 29, 2017
Initiation Date
Mar 2, 2017
Termination Date
Jul 2, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14,665 tubes

Product description

Desonide Ointment, 0.05%, NET WT 60 grams tubes, Rx only, E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0309-60

Reason for recall

Labeling: Label Mixup; Unit boxes labeled as Desonide Ointment 0.05% may contain tubes of Desonide Ointment labeled as Ketoconazole Cream

Distribution pattern

Nationwide

Code information

Lot GC9231 (exp. 05/2019); Lot GC9232 (exp. 05/2019)

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0612-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0612-2017. Report a data issue: hello@regdatalab.com.